Clinical Trials for Drug: Ibrutinib

2 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-14-93 UCReliance#1415_Phase 1b Trial of the Combination of Ibrutinib and Azacitidine for the Treatment of Higher Risk Myelodysplastic Syndromes in Previously Treated Patients or in Untreated Patients Unfit for or Who Refuse Intense Therapy Open
UCI-16-65 A Phase 1 clinical trial to evaluate obinutuzumab with high-dose ibrutinib for the treatment of patients with chronic lymphocytic leukemia with progressive disease on single agent ibrutinib Open